Sterling Capital Management LLC lessened its holdings in Humana Inc. (NYSE:HUM – Free Report) by 43.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,155 shares of the insurance provider’s stock after selling 3,167 shares during the quarter. Sterling Capital Management LLC’s holdings in Humana were worth $720,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of HUM. Montag A & Associates Inc. increased its holdings in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares in the last quarter. CoreCap Advisors LLC grew its position in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac acquired a new position in Humana during the 4th quarter valued at approximately $27,000. Reflection Asset Management purchased a new position in shares of Humana in the fourth quarter worth $29,000. Finally, Rosenberg Matthew Hamilton raised its holdings in shares of Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after buying an additional 68 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on HUM. Wells Fargo & Company lowered shares of Humana from a “cautious” rating to a “reduce” rating in a report on Wednesday, May 20th. Robert W. Baird reduced their target price on Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Oppenheimer raised Humana from an “outperform” rating to an “outperform” rating in a research report on Wednesday, May 20th. Needham & Company LLC started coverage on Humana in a research note on Wednesday, May 20th. They set a “buy” rating on the stock. Finally, Piper Sandler reissued a “neutral” rating and issued a $254.00 price objective (up from $182.00) on shares of Humana in a report on Wednesday, May 13th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $293.09.
Humana Price Performance
NYSE:HUM opened at $409.92 on Thursday. The stock has a 50 day moving average of $314.71 and a two-hundred day moving average of $248.64. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $414.82. The firm has a market cap of $49.22 billion, a P/E ratio of 43.84, a price-to-earnings-growth ratio of 2.26 and a beta of 0.71. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66.
Humana (NYSE:HUM – Get Free Report) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same quarter last year, the business posted $11.58 earnings per share. The business’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. On average, analysts expect that Humana Inc. will post 9.04 earnings per share for the current fiscal year.
Humana Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s payout ratio is 37.86%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
